Polen Capital Management LLC
CIK 0001034524 · As of Q2 2014 · filed Aug 13, 2014
| Allergan Inc | 9.3% | Reduced −4.8% | 2,521,174 | $426.6M |
| V VISA INC-CLASS A SHARES | 6.8% | Reduced −4.9% | 1,479,020 | $311.6M |
| QCOM QUALCOMM INC | 6.8% | Reduced −5.0% | 3,909,900 | $309.7M |
| ABT ABBOTT LABORATORIES | 6.4% | Reduced −5.0% | 7,209,397 | $294.9M |
| ORCL ORACLE CORP | 6.4% | Reduced −4.9% | 7,216,244 | $292.5M |
| NKE NIKE INC -CL B | 5.9% | Reduced −4.9% | 3,490,821 | $270.7M |
| SBUX STARBUCKS CORP | 5.4% | Reduced −4.9% | 3,193,453 | $247.1M |
| ACN ACCENTURE PLC-CL A | 4.8% | Reduced −4.9% | 2,710,303 | $219.1M |
| Google Inc | 4.5% | Reduced −5.2% | 350,817 | $205.1M |
| Google Inc | 4.4% | New | 354,040 | $203.7M |
| NSRGY NESTLE SA-SPONS ADR | 4.4% | New | 2,604,908 | $202.3M |
| AAPL APPLE INC | 4.3% | Added +565.4% | 2,119,952 | $197.0M |
| TROW T ROWE PRICE GROUP INC | 4.1% | Reduced −37.7% | 2,243,095 | $189.3M |
| ADP AUTOMATIC DATA PROCESSING | 4.1% | Reduced −4.3% | 2,346,645 | $186.0M |
| GWW WW GRAINGER INC | 3.5% | Reduced −4.6% | 624,805 | $158.9M |
| IT GARTNER INC | 3.5% | Reduced −4.9% | 2,252,810 | $158.9M |
| TJX TJX COMPANIES INC | 3.5% | Reduced −5.2% | 2,981,132 | $158.4M |
| FDS FACTSET RESEARCH SYSTEMS INC | 3.4% | Reduced −5.2% | 1,290,711 | $155.2M |
| FAST FASTENAL CO | 3.2% | Reduced −4.7% | 2,926,668 | $144.8M |
| Priceline Grp Inc | 2.1% | New | 79,437 | $95.6M |
| MA MASTERCARD INC - A | 2.0% | Reduced −4.8% | 1,239,255 | $91.0M |
| REGN REGENERON PHARMACEUTICALS | 1.3% | Reduced −4.8% | 208,590 | $58.9M |
| IWF ISHARES RUSSELL 1000 GROWTH | 0.0% | Added +132.9% | 13,557 | $1.2M |
| Solarwinds Inc | 0.0% | Reduced −4.9% | 13,770 | $532K |
| SAP SAP SE-SPONSORED ADR | 0.0% | Held | 5,150 | $397K |
Sold positions
| Holding | Shares sold | Prior value |
|---|---|---|
| EBAY EBAY INC | 4,236,029 | $234.0M |
Holdings reflect long positions disclosed in 13F filings only and exclude short positions, cash, and other non-13F assets. Holdings data sourced from SEC EDGAR. Not investment advice. Full disclaimer.